Hepatic and neuromuscular forms of glycogen storage disease type IV caused by mutations in the same glycogen-branching enzyme gene
- PMID:8613547
- PMCID: PMC507139
- DOI: 10.1172/JCI118517
Hepatic and neuromuscular forms of glycogen storage disease type IV caused by mutations in the same glycogen-branching enzyme gene
Abstract
Glycogen storage disease type IV (GSD-IV) is an autosomal recessive disease resulting from deficient glycogen-branching enzyme (GBE) activity. The classic and most common form is progressive liver cirrhosis and failure leading to either liver transplantation or death by 5 yr of age. However, the liver disease is not always progressive. In addition, a neuromuscular type of the disease has been reported. The molecular basis of GSD-IV is not known, nor is there a known reason for the clinical variability. We studied the GBE gene in patients with various presentations of GSD-IV. Three point mutations in the GBE gene were found in two patients with the classical presentation: R515C, F257L, and R524X. Transient expression experiments showed that these mutations inactivated GBE activity. Two point mutations, L224P and Y329S, were detected in two separate alleles of a patient with the nonprogressive hepatic form. The L224P resulted in complete loss of GBE activity, whereas the Y329S resulted in loss of approximately 50% of GBE activity. The Y329S allele was also detected in another patient with the nonprogressive form of GSD-IV but not in 35 unrelated controls or in patients with the more severe forms of GSD-IV. A 210-bp deletion from nucleotide 873 to 1082 of the GBE cDNA was detected in a patient with the fatal neonatal neuromuscular presentation. This deletion, representing the loss of one full exon, was caused by a 3' acceptor splicing site mutation (ag to aa). The deletion abolished GBE activity. Our studies indicate that the three different forms of GSD-IV were caused by mutations in the same GBE gene. The data also suggest that the significant retention of GBE activity in the Y329S allele may be a reason for the mild disease. Further study of genotype/phenotype correlations may yield useful information in predicting the clinical outcomes.
Similar articles
- The variable presentations of glycogen storage disease type IV: a review of clinical, enzymatic and molecular studies.Moses SW, Parvari R.Moses SW, et al.Curr Mol Med. 2002 Mar;2(2):177-88. doi: 10.2174/1566524024605815.Curr Mol Med. 2002.PMID:11949934Review.
- Clinical and genetic heterogeneity of branching enzyme deficiency (glycogenosis type IV).Bruno C, van Diggelen OP, Cassandrini D, Gimpelev M, Giuffrè B, Donati MA, Introvini P, Alegria A, Assereto S, Morandi L, Mora M, Tonoli E, Mascelli S, Traverso M, Pasquini E, Bado M, Vilarinho L, van Noort G, Mosca F, DiMauro S, Zara F, Minetti C.Bruno C, et al.Neurology. 2004 Sep 28;63(6):1053-8. doi: 10.1212/01.wnl.0000138429.11433.0d.Neurology. 2004.PMID:15452297
- A complex rearrangement in GBE1 causes both perinatal hypoglycemic collapse and late-juvenile-onset neuromuscular degeneration in glycogen storage disease type IV of Norwegian forest cats.Fyfe JC, Kurzhals RL, Hawkins MG, Wang P, Yuhki N, Giger U, Van Winkle TJ, Haskins ME, Patterson DF, Henthorn PS.Fyfe JC, et al.Mol Genet Metab. 2007 Apr;90(4):383-92. doi: 10.1016/j.ymgme.2006.12.003. Epub 2007 Jan 25.Mol Genet Metab. 2007.PMID:17257876Free PMC article.
- Glycogen storage disease type IV: novel mutations and molecular characterization of a heterogeneous disorder.Li SC, Chen CM, Goldstein JL, Wu JY, Lemyre E, Burrow TA, Kang PB, Chen YT, Bali DS.Li SC, et al.J Inherit Metab Dis. 2010 Dec;33 Suppl 3:S83-90. doi: 10.1007/s10545-009-9026-5. Epub 2010 Jan 8.J Inherit Metab Dis. 2010.PMID:20058079
- Diffuse reticuloendothelial system involvement in type IV glycogen storage disease with a novel GBE1 mutation: a case report and review.Magoulas PL, El-Hattab AW, Roy A, Bali DS, Finegold MJ, Craigen WJ.Magoulas PL, et al.Hum Pathol. 2012 Jun;43(6):943-51. doi: 10.1016/j.humpath.2011.10.001. Epub 2012 Feb 2.Hum Pathol. 2012.PMID:22305237Review.
Cited by
- Analysis ofGBE1 mutations via protein expression studies in glycogen storage disease type IV: A report on a non-progressive form with a literature review.Iijima H, Iwano R, Tanaka Y, Muroya K, Fukuda T, Sugie H, Kurosawa K, Adachi M.Iijima H, et al.Mol Genet Metab Rep. 2018 Sep 13;17:31-37. doi: 10.1016/j.ymgmr.2018.09.001. eCollection 2018 Dec.Mol Genet Metab Rep. 2018.PMID:30228975Free PMC article.
- Liver Transplantation for Glycogen Storage Disease Type IV.Liu M, Sun LY.Liu M, et al.Front Pediatr. 2021 Feb 19;9:633822. doi: 10.3389/fped.2021.633822. eCollection 2021.Front Pediatr. 2021.PMID:33681109Free PMC article.Review.
- Liver transplantation for glycogen storage disease types I, III, and IV.Matern D, Starzl TE, Arnaout W, Barnard J, Bynon JS, Dhawan A, Emond J, Haagsma EB, Hug G, Lachaux A, Smit GP, Chen YT.Matern D, et al.Eur J Pediatr. 1999 Dec;158 Suppl 2(Suppl 2):S43-8. doi: 10.1007/pl00014320.Eur J Pediatr. 1999.PMID:10603098Free PMC article.Review.
- Skeletal Muscle Glycogen Chain Length Correlates with Insolubility in Mouse Models of Polyglucosan-Associated Neurodegenerative Diseases.Sullivan MA, Nitschke S, Skwara EP, Wang P, Zhao X, Pan XS, Chown EE, Wang T, Perri AM, Lee JPY, Vilaplana F, Minassian BA, Nitschke F.Sullivan MA, et al.Cell Rep. 2019 Apr 30;27(5):1334-1344.e6. doi: 10.1016/j.celrep.2019.04.017.Cell Rep. 2019.PMID:31042462Free PMC article.
- Specific features of glycogen metabolism in the liver.Bollen M, Keppens S, Stalmans W.Bollen M, et al.Biochem J. 1998 Nov 15;336 ( Pt 1)(Pt 1):19-31. doi: 10.1042/bj3360019.Biochem J. 1998.PMID:9806880Free PMC article.Review.
References
Publication types
MeSH terms
Substances
Related information
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials